MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.ppat.1009024

Медицинская библиотека · PLoS pathogens · 2020

Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism.

Cheu Ryan K, Gustin Andrew T, Lee Christina, Schifanella Luca, Miller Charlene J, Ha Avie, Kim Casey, Rodriguez Violeta J, Fischl Margaret, Burgener Adam D, Arnold Kelly B, Alcaide Maria L, Klatt Nichole R

СтатьяПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

Despite the efficacy of antiretroviral-based pre-exposure prophylactics (PrEP) in men who have sex with men, studies in women have produced widely varying outcomes. Recent evidence demonstrates that vaginal microbial communities are associated with increased HIV acquisition risk and may impact PrEP efficacy. Here, we investigate the mechanisms underlying how vaginal bacteria alter PrEP drug levels and impact HIV infection rates ex vivo. Using cervicovaginal lavages (CVLs) from women with or without bacterial vaginosis (BV), we identified microbial metabolism of PrEP drugs in BV samples through LC-MS/MS analysis of soluble drug levels and metabolite formation in dual T-cell cultures. CVL samples were assessed for microbiome analysis using sequencing of bacterial 16S rRNA genes. We also observed non-Lactobacillus bacteria that are associated with BV may potentially impact PrEP efficacy through increased HIV infection rates in co-cultures containing Lactobacillus or BV bacteria, PrEP drugs, CEM-GFP cells, and HIV-1LAI virus. Finally, we used these data to develop a novel predictive mathematical simulation modeling system to predict these drug interactions for future trials. These studies demonstrate how dysbiotic vaginal microbiota may impact PrEP drugs and provides evidence linking vaginal bacteria to PrEP efficacy in women.

Для цитирования: Cheu Ryan K, Gustin Andrew T, Lee Christina, Schifanella Luca, Miller Charlene J, Ha Avie, Kim Casey, Rodriguez Violeta J, Fischl Margaret, Burgener Adam D, Arnold Kelly B, Alcaide Maria L, Klatt Nichole R. Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism.. PLoS pathogens. 2020. DOI: 10.1371/journal.ppat.1009024.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.